State Of Wyoming Allovir, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.26 - $7.06 $1,036 - $2,245	-318 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.75 - $13.52 $776 - $1,554	115 Added 56.65%	318 $2,000
Q4 2021 Feb 11, 2022	SELL	$12.94 - $25.99 $1,371 - $2,754	-106 Reduced 34.3%	203 $3,000
Q3 2021 Feb 11, 2022	SELL	$16.97 - $25.06 $4,853 - $7,167	-286 Reduced 48.07%	309 $8,000
Q2 2021 Feb 11, 2022	BUY	$19.44 - $25.06 $6,084 - $7,843	313 Added 110.99%	595 $12,000
Q1 2021 Feb 08, 2022	BUY	$20.81 - $45.5 $5,868 - $12,831	282 New	282 $7,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $53M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.